nonclinical drug development blog posts

29 March, 2018

Non-clinical drug development trends that will get you to market sooner

By Freddie Campbell

Two scientists working on nonclinical drug development projects

The pressure of looming patent expirations and the need for strengthened clinical development pipelines is driving the growth to address the demand of new medicines. In response to this pressure, the total number of molecules in development has grown consistently in recent years, with the largest growth seen in non-clinical drug development. 

Here we talk to four Envigo scientists, all working in different areas of the non-clinical setting, to get their take on the current trends of drug development and how these strategies and technologies can help you get to market sooner.

+ Read more